| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bddc1dfd002d0546cd6d49b2ade465e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a1f378f2175937526294d29c4cbdab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3985f402e206ac83d4108023fdd4c685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acd8a642d270e931c137d418d68c9cc9 |
| publicationDate |
2022-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114432440-A |
| titleOfInvention |
Treatment of kidney cancer using an anti-PD-1 antibody in combination with another anticancer agent |
| abstract |
The present disclosure provides methods for treating an individual with renal cancer, the method comprising administering to the individual a therapeutically effective amount of: (a) specifically binds to the programmed death-1 (PD-1) receptor and An anticancer agent of an antibody or antigen-binding portion thereof that inhibits PD-1 activity; and (b) another anticancer agent. The other anti-cancer agent may be an anti-angiogenic tyrosine kinase inhibitor or an anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) antibody. The present disclosure also provides kits for treating an individual with kidney cancer, the kits comprising a dose of an anti-PD-1 antibody, a dose of an anti-angiogenic tyrosine kinase inhibitor or an anti-CTLA- 4. Another anti-cancer agent of the antibody and instructions for using the anti-PD-1 antibody with the other anti-cancer agent in any of the disclosed methods for treating kidney cancer. |
| priorityDate |
2014-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |